Compare SUPN & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | PRDO |
|---|---|---|
| Founded | 2005 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 2014 | 1997 |
| Metric | SUPN | PRDO |
|---|---|---|
| Price | $26.85 | $26.51 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $60.50 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 510.6K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | ★ 8100.00 | 10.50 |
| EPS | ★ 2.78 | 1.60 |
| Revenue | ★ $1,239,000,000.00 | $581,296,000.00 |
| Revenue This Year | $23.01 | $0.99 |
| Revenue Next Year | $15.28 | $2.98 |
| P/E Ratio | ★ N/A | $18.74 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $26.74 | $26.66 |
| 52 Week High | $59.68 | $38.50 |
| Indicator | SUPN | PRDO |
|---|---|---|
| Relative Strength Index (RSI) | 19.93 | 33.28 |
| Support Level | N/A | $29.35 |
| Resistance Level | $51.59 | $34.94 |
| Average True Range (ATR) | 2.21 | 1.04 |
| MACD | -1.14 | -0.43 |
| Stochastic Oscillator | 8.37 | 14.37 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.